BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 16983529)

  • 1. [Salvage radical prostatectomy].
    Hautmann RE
    Urologe A; 2006 Oct; 45(10):1260-5. PubMed ID: 16983529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
    Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
    Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited.
    Vaidya A; Soloway MS
    J Urol; 2000 Dec; 164(6):1998-2001. PubMed ID: 11061900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brachytherapy for the treatment of recurrent prostate cancer after radiotherapy or radical prostatectomy.
    Gomez-Veiga F; Mariño A; Alvarez L; Rodriguez I; Fernandez C; Pertega S; Candal A
    BJU Int; 2012 Feb; 109 Suppl 1():17-21. PubMed ID: 22239225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radical salvage prostatectomy : Treatment of local recurrence of prostate cancer after radiotherapy].
    Heidenreich A; Semrau R; Thüer D; Pfister D
    Urologe A; 2008 Nov; 47(11):1441-6. PubMed ID: 18806991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.
    Do T; Parker RG; Do C; Tran L; Do L; Dolkar D
    Cancer J Sci Am; 1998; 4(5):324-30. PubMed ID: 9815297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?
    MacDonald OK; Schild SE; Vora S; Andrews PE; Ferrigni RG; Novicki DE; Swanson SK; Wong WW
    Urology; 2004 Oct; 64(4):760-4. PubMed ID: 15491716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy.
    Heidenreich A; Richter S; Thüer D; Pfister D
    Eur Urol; 2010 Mar; 57(3):437-43. PubMed ID: 19303197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184 consecutive patients treated with 70 Gy.
    Cortés-González JR; Castellanos E; Sandberg K; Eriksson MH; Wiklund P; Carlsson S; Cohn-Cedermark G; Harmenberg U; Gustafsson O; Levitt SH; Lennernäs B; Brandberg Y; Márquez M; Kälkner KM; Nilsson S
    Int J Oncol; 2013 Jan; 42(1):109-17. PubMed ID: 23151842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
    Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
    Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status and outcomes of patients developing PSA recurrence after prostatectomy who were treated with salvage radiotherapy: a JROSG surveillance study.
    Mizowaki T; Aoki M; Nakamura K; Yorozu A; Kokubo M; Karasawa K; Kozuka T; Nakajima N; Sasai K; Akimoto T
    J Radiat Res; 2015 Jul; 56(4):750-6. PubMed ID: 25910489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant and salvage radiotherapy after radical prostatectomy.
    Höcht S; Wiegel T; Schostak M; Hinkelbein W
    Onkologie; 2002 Jun; 25(3):201-6. PubMed ID: 12119453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.
    Bianco FJ; Scardino PT; Stephenson AJ; Diblasio CJ; Fearn PA; Eastham JA
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):448-53. PubMed ID: 15890586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer.
    Sanderson KM; Penson DF; Cai J; Groshen S; Stein JP; Lieskovsky G; Skinner DG
    J Urol; 2006 Nov; 176(5):2025-31; discussion 2031-2. PubMed ID: 17070244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors predicting the outcome of salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy.
    Kinoshita H; Shimizu Y; Mizowaki T; Takayama K; Norihisa Y; Kamoto T; Kamba T; Hayashino Y; Hiraoka M; Ogawa O
    Int J Urol; 2013 Aug; 20(8):806-11. PubMed ID: 23293977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes.
    Palermo G; Totaro A; Sacco E; Foschi N; Gulino G; Racioppi M; Bassi P; Pinto F
    Minerva Urol Nefrol; 2017 Feb; 69(1):93-100. PubMed ID: 28009150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy?
    Koppie TM; Grossfeld GD; Nudell DM; Weinberg VK; Carroll PR
    J Urol; 2001 Jul; 166(1):111-5. PubMed ID: 11435834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels.
    Rogers E; Ohori M; Kassabian VS; Wheeler TM; Scardino PT
    J Urol; 1995 Jan; 153(1):104-10. PubMed ID: 7526002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.